Drug Formulation R&D

History has shown that drug formulation can have a substantial impact on nearly every quality characteristic of an API including potency, bioavailability, solubility, dosage, route of administration and stability. Inimmune offers parenteral drug formulation R&D services for early stage and preclinical candidates with a special emphasis in nanoparticle based drug delivery technology. Our formulation team has over 40 years of combined experience in API formulation and associated analytical method development with a particular focus on vaccines and immunotherapeutics. The Inimmune team can help you troubleshoot existing formulations issues or develop novel formulations suited for your application and business need.

Formulations experience and capabilities include but are not limited to:

  • Salt screening
  • Co-Solvent studies
  • Liposomes
  • Block copolymers (such as PLGA)
  • Nanoemulsions
  • Solid Lipid Nanoparticles (SLNs)
  • Alum based formulations

Copyright © 2019 Inimmune